跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ELIQUIS apixaban 2.5 mg film-coated tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
ELIQUIS apixaban 2.5 mg film-coated tablet blister pack
Approved
STANDARD
ELIQUIS apixaban 2.5 mg film-coated tablet blister pack
Bristol-Myers Squibb Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
122ffc71dfd4d7a6
Company
Bristol-Myers Squibb Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
122ffc71dfd4d7a6
Product Name
ELIQUIS apixaban 2.5 mg film-coated tablet blister pack
Artg Id
172244
Artg Name
ELIQUIS apixaban 2.5 mg film-coated tablet blister pack
Sponsor
Bristol-Myers Squibb Australia Pty Ltd
Company Detail Path
/organization/bristol-myers-squibb-australia-pty-ltd
Artg Date
2011-07-21
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/77db9b93ac80f829ea98c3bc43dbcb2b.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/b71a3f87eb45bf722a7762b1ea73207a.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
122ffc71dfd4d7a6
Type
Standard
Back to TGA Approvals